SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052273
Filing Date
2020-11-09
Accepted
2020-11-09 09:53:58
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20200930.htm   iXBRL 10-Q 3021590
2 EX-10.1 mcrb-ex101_219.htm EX-10.1 202354
3 EX-31.1 mcrb-ex311_11.htm EX-31.1 10567
4 EX-31.2 mcrb-ex312_7.htm EX-31.2 10492
5 EX-32.1 mcrb-ex321_6.htm EX-32.1 7367
6 EX-32.2 mcrb-ex322_8.htm EX-32.2 7470
  Complete submission text file 0001564590-20-052273.txt   9188436

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20200930.xsd EX-101.SCH 55423
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20200930_cal.xml EX-101.CAL 50110
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20200930_def.xml EX-101.DEF 167395
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20200930_lab.xml EX-101.LAB 432906
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20200930_pre.xml EX-101.PRE 322770
12 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-10q_20200930_htm.xml XML 1514574
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 201296410
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences